 |
|
The Effect of the Timing of Dexamethasone Administration in Patients with COVID-19 Pneumonia
Hyun Woo Lee, Jimyung Park, Jung-Kyu Lee, Tae Yeon Park, Eun Young Heo
Tuberc Respir Dis. 2021;84(3):217-225. Published online 2021 Mar 29 DOI: https://doi.org/10.4046/trd.2021.0009
|
|
Citations to this article as recorded by
 Association between patient-reported onset-to-door time and mortality in patients hospitalized with COVID-19 disease
Kuldeep N. Yadav, Jessica Hemmons, Christopher K. Snider, Arjun Patel, Maya Childs, M. Kit Delgado
The American Journal of Emergency Medicine.2024; 77: 169. CrossRef Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study
Sana Asif, Robert Frithiof, Anders Larsson, Stephanie Franzén, Sara Bülow Anderberg, Bjarne Kristensen, Michael Hultström, Miklos Lipcsey
Biomedicines.2023; 11(1): 164. CrossRef Deep Learning With Chest Radiographs for Making Prognoses in Patients With COVID-19: Retrospective Cohort Study
Hyun Woo Lee, Hyun Jun Yang, Hyungjin Kim, Ue-Hwan Kim, Dong Hyun Kim, Soon Ho Yoon, Soo-Youn Ham, Bo Da Nam, Kum Ju Chae, Dabee Lee, Jin Young Yoo, So Hyeon Bak, Jin Young Kim, Jin Hwan Kim, Ki Beom Kim, Jung Im Jung, Jae-Kwang Lim, Jong Eun Lee, Myung J
Journal of Medical Internet Research.2023; 25: e42717. CrossRef Comparison of COVID-19 Preprint and Peer-Reviewed Versions of Studies on Therapies for Critically Ill Patients
Conor Morin, Anirudh Padki, Adrian Wong, Todd Miano, Sandra L. Kane-Gill, Gabrielle Cozzi, Robert Deveau
Journal of Intensive Care Medicine.2023; 38(11): 1060. CrossRef Plasma matrix metalloproteinase-3 predicts mortality in acute respiratory distress syndrome: a biomarker analysis of a randomized controlled trial
Timothy W. Jones, Sultan Almuntashiri, Aaron Chase, Abdullah Alhumaid, Payaningal R. Somanath, Andrea Sikora, Duo Zhang
Respiratory Research.2023;[Epub] CrossRef Managing hospitalized patients with COVID-19
Mike Stricker
JAAPA.2023; 36(10): 16. CrossRef Steroid initiation timing and outcome of coronavirus disease 2019 patients: A multicenter, retrospective, observational study
Ryu Sugimoto, Tsuneaki Kenzaka, Ayako Mikami, Nobuaki Matsunaga, Takayuki Akiyama, Norio Ohmagari, Hogara Nishisaki
International Journal of Immunopathology and Pharmacology.2023;[Epub] CrossRef Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
Ching-Lung Lo, Ling-Shan Syue, Wen-Chien Ko
Journal of Microbiology, Immunology and Infection.2022; 55(1): 170. CrossRef Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical condition
Yuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, Yoshihiro Fujiya, Koji Kuronuma, Takeshi Tsugawa, Satoshi Takahashi, Masahide Fukudo
Journal of Infection and Chemotherapy.2022; 28(7): 875. CrossRef Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease
Elliot M. Frohman, Nicole R. Villemarette-Pittman, Adriana Rodriguez, Robert Glanzman, Sarah Rugheimer, Oleg Komogortsev, Scott S. Zamvil, Roberto Alejandro Cruz, Thomas C. Varkey, Ashley N. Frohman, Audrey R. Frohman, Matthew S. Parsons, Emily Heckmann K
Journal of the Neurological Sciences.2021; 426: 117463. CrossRef
|